Search results
Stopping the march: Can effective treatment of psoriasis prevent progression to psoriatic arthritis?
Medical Xpress· 2 days agoPsoriatic arthritis (PsA) is a chronic inflammatory arthritis which appears in around one-third of...
UCB to share first presentations of BIMZELX® (bimekizumab-bkzx) two-year data in axial...
Williamson Daily News· 2 days agoThe impact of BIMZELX treatment on two-year radiographic progression in the spine of patients with...
Exploring whether different joints have different treatment outcomes in cases of psoriatic arthritis
Medical Xpress· 2 days agoThere are many treatment options for psoriatic arthritis (PsA), and EULAR—The European Alliance of...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 47 minutes agoIn June 2024 AbbVie announced that its RINVOQ (upadacitinib) is now indicated for treating...
Achieving drug-free remission in axial spondyloarthritis: Exploring the role of tight control in...
Medical Xpress· 12 hours agoEarly therapeutic interventions in inflammatory rheumatic diseases have proven successful in...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 4 days agoBoth medicines are TYK2 inhibitors, a group of oral medicines that drugmakers are positioning as...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Oklahoma Voice via Yahoo News· 15 hours agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
The Best Products For Treating Psoriasis, According To Dermatologists
HuffPost· 2 days ago“[It] commonly arises on the scalp, ears, elbows, knees and nails,” she said. “In addition to the...
Shell Asset Management Co. Sells 9,507 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoShell Asset Management Co. cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 19.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities ...